35-45kDa (Reducing)
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
Jingchao Bai , Hui Li. Targeting TNFR2 in Cancer: All Roads Lead to Rome. Front Immunol. 2022 Feb 17:13:844931. eCollection 2022.
TNF receptor 2 (TNFR2) has become one of the best potential immune checkpoints that might be targeted, mainly because of its vital role in tumor microenvironments (TMEs). Overexpression of TNFR2 in some tumor cells and essential function in immunosuppressive cells, especially regulatory T cells (Tregs), makes blocking TNFR2 an excellent strategy in cancer treatment; however, there is evidence showing that activating TNFR2 can also inhibit tumor progression in vivo.
2μg (R: reducing condition, N: non-reducing condition).
Anti-His antibody Immobilized on CM5 Chip captured TNFR-2/CD120b His Tag, Cynomolgus (Cat. No. UA010721), can bind TNF-α, Human (Cat. No. UA040005) with an affinity constant of 0.46 nM as determined in SPR assay.